1. Effect of the oxytocin receptor antagonist nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomised clinical trials. Issue 4 (4th February 2021) Authors: Griesinger, G; Blockeel, C; Pierzynski, P; Tournaye, , H; Višňová, H; Humberstone, A; Terrill, P; Pohl, O; Garner, E; Donnez, J; Loumaye, E Journal: Human reproduction Issue: Volume 36:Issue 4(2021) Page Start: 1007 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Mental health curricula and Mental Health First Aid in the MPharm. (26th March 2021) Authors: Gorton, H C; Macfarlane, H; Edwards, R; Farid, S; Garner, E; Mahroof, M; Rasul, S; Keating, D; Zaman, H; Scott, J; Maidment, I; Strawbridge, J Journal: International journal of pharmacy practice Issue: Volume 29(2021)Supplement 1 Page Start: i37 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. O-135 Long term secondary efficacy of linzagolix for heavy menstrual bleeding (HMB) due to uterine fibroids (UF): 52-week results from two placebo-controlled, randomized, phase 3 trials. (6th August 2021) Authors: Taylor, H; Donnez, J; Petraglia, F; Gemzell Danielsson, K; Renner, S; Bestel, E; Gotteland, J P; Humberstone, A; Garner, E Journal: Human reproduction Issue: Volume 36:Supplement 1(2021) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. O-306 LINZAGOLIX FOR ENDOMETRIOSIS-ASSOCIATED PAIN: SAFETY RESULTS FROM EDELWEISS 3, A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL. (30th June 2022) Authors: Donnez, J; Taylor, H; Gemzell-Danielsson, K; Catherino, W; Bestel, E; Gotteland, J.P; Humberstone, A; Moore, L; Garner, E Journal: Human reproduction Issue: Volume 37(2022)Supplement 1 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗